Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Sep 26:2024:3076895.
doi: 10.1155/2024/3076895. eCollection 2024.

Whole Exome Sequencing in Children With Type 1 Diabetes Before Age 6 Years Reveals Insights Into Disease Heterogeneity

Affiliations

Whole Exome Sequencing in Children With Type 1 Diabetes Before Age 6 Years Reveals Insights Into Disease Heterogeneity

Andreia Fiúza Ribeiro et al. J Diabetes Res. .

Abstract

Aims: This study is aimed at comparing whole exome sequencing (WES) data with the clinical presentation in children with type 1 diabetes onset ≤ 5 years of age (EOT1D). Methods: WES was performed in 99 unrelated children with EOT1D with subsequent analysis to identify potentially deleterious rare variants in MODY genes. High-resolution HLA class II haplotyping, SNP genotyping, and T1D-genetic risk score (T1D-GRS) were also evaluated. Results: Eight of the ninety-nine EOT1D participants carried a potentially deleterious rare variant in a MODY gene. Rare variants affected five genes: GCK (n = 1), HNF1B (n = 2), HNF4A (n = 1), PDX1 (n = 2), and RFX6 (n = 2). At diagnosis, these children had a mean age of 3.0 years, a mean HbA1c of 10.5%, a detectable C-peptide in 5/8, and a positive islet autoantibody in 6/7. Children with MODY variants tend to exhibit a lower number of pancreatic autoantibodies and a lower fasting C-peptide compared to EOT1D without MODY rare variants. They also carried at least one high-risk DR3-DQ2 or DR4-DQ8 haplotype and exhibited a T1D-GRS similar to the other individuals in the EOT1D cohort, but higher than healthy controls. Conclusions: WES found potentially deleterious rare variants in MODY genes in 8.1% of EOT1D, occurring in the context of a T1D genetic background. Such genetic variants may contribute to disease precipitation by a β-cell dysfunction mechanism. This supports the concept of different endotypes of T1D, and WES at T1D onset may be a prerequisite for the implementation of precision therapies in children with autoimmune diabetes.

Keywords: MODY; early-onset; type 1 diabetes; whole exome sequencing; β-cell dysfunction.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
T1D-GRS is similar in EOT1D children regardless of the presence of rare variants in MODY genes. (a) Boxplot of T1D-GRS from 171 healthy controls (Ctr), 91 EOT1D children without deleterious rare variants in MODY genes, and 8 EOT1D children with potentially deleterious MODY rare variants. The central line within the box represents the median, and the upper and lower limits of the box represent the IQR (interquartile range). Lower and upper whiskers cover the lowest and highest 25% of data, respectively. The horizontal line shows a GRS equivalent to the 5th percentile for the control group, used to divide T1D children into high GRS (above the 5th percentile) and low GRS (below the 5th percentile). Mann–Whitney test was used for comparison between groups (∗∗∗∗p < 1 × 10−4). (b) ROC curve (area under the curve 0.9125) for T1D-GRS to discriminate EOT1D children without deleterious MODY rare variants (n = 91) from controls (n = 171).

References

    1. International Diabetes Federation. IDF Atlas Reports. Type 1 diabetes numbers in children and adults -2022. January 2024, https://diabetesatlas.org/idfawp/resource-files/2022/12/IDF-T1D-Index-Re....
    1. Noble J. A., Valdes A. M., Cook M., Klitz W., Thomson G., Erlich H. A. The role of HLA class II genes in insulin-dependent diabetes mellitus: molecular analysis of 180 Caucasian, multiplex families. American Journal of Human Genetics . 1996;59(5):1134–1148. - PMC - PubMed
    1. Onengut-Gumuscu S., Chen W.-M., Burren O., et al. Fine mapping of type 1 diabetes susceptibility loci and evidence for colocalization of causal variants with lymphoid gene enhancers. Nature Genetics . 2015;47(4):381–386. doi: 10.1038/ng.3245. - DOI - PMC - PubMed
    1. Oram R. A., Patel K., Hill A., et al. A type 1 diabetes genetic risk score can aid discrimination between type 1 and type 2 diabetes in young adults. Diabetes Care . 2016;39(3):337–344. doi: 10.2337/dc15-1111. - DOI - PMC - PubMed
    1. Patel K. A., Oram R. A., Flanagan S. E., et al. Type 1 diabetes genetic risk score: a novel tool to discriminate monogenic and type 1 diabetes. Diabetes . 2016;65(7):2094–2099. doi: 10.2337/db15-1690. - DOI - PMC - PubMed

MeSH terms